PREGABALIN
- Product NDC
- 71209-032
- 11-digit product format
- 712090032
- Labeler code
- 71209
- Product ID
- 71209-032_be6557c8-0d68-4313-a689-c2fdfb1d505e
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- PREGABALIN
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Cadila Pharmaceuticals Limited
- Application
- ANDA206452
- Marketing category
- ANDA
- Marketing start
- 2023-07-13
- Substance
- PREGABALIN
- Active strength
- 25 mg/1
- DEA schedule
- CV
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- PREGABALIN
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| PREGABALIN | 25 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 55JG375S6M |
| Rxcui | 483438, 483440, 483442, 483444, 483446, 483448, 483450, 577127 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 71209-032-04 | PREGABALIN | 90 in 1 BOTTLE | CAPSULE | 90 | | 11 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 71209-032 | PREGABALIN CAPSULE [CADILA PHARMACEUTICALS LIMITED] | 10 | Current NDC, 1 package rows | 20240515_170c0c95-2ee8-4dff-bbd6-b87a21e8cf81.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 71209-032-04 | 71209003204 | 90 CAPSULE in 1 BOTTLE (71209-032-04) | 90 capsule | 2023-07-13 | No | No | Current |